Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen.
J Control Release
; 350: 630-641, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36058352
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B Surface Antigens
/
Liver Neoplasms
Limits:
Animals
Language:
En
Journal:
J Control Release
Journal subject:
FARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: